IRIS
STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.315
EU - Europa 1.207
AS - Asia 795
AF - Africa 181
SA - Sud America 17
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.291
SG - Singapore 377
FI - Finlandia 364
CN - Cina 288
IE - Irlanda 259
NG - Nigeria 177
DE - Germania 114
SE - Svezia 102
FR - Francia 95
IT - Italia 83
NL - Olanda 73
IN - India 62
GB - Regno Unito 38
TR - Turchia 25
RU - Federazione Russa 21
CA - Canada 20
BE - Belgio 18
AU - Australia 8
BR - Brasile 8
IL - Israele 8
GR - Grecia 7
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
HK - Hong Kong 5
JP - Giappone 5
RO - Romania 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
ES - Italia 4
NZ - Nuova Zelanda 4
PE - Perù 4
UA - Ucraina 4
CL - Cile 3
CU - Cuba 3
PH - Filippine 3
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
SA - Arabia Saudita 2
UG - Uganda 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
VN - Vietnam 1
Totale 7.532
Salva come PNG Salva come JPEG
Città #
Chandler 980
Wilmington 956
San Mateo 417
Helsinki 364
Shanghai 263
Boardman 259
Dublin 258
Singapore 253
Ann Arbor 228
Ashburn 196
Lawrence 181
Princeton 181
Benin City 177
New York 177
Leawood 147
Woodbridge 98
Fairfield 90
Paris 89
Amsterdam 72
Pune 55
Seattle 37
Los Angeles 33
Kocaeli 24
London 24
Milan 24
Norwalk 20
San Diego 19
Brussels 18
Santa Clara 17
Cologno Monzese 16
Falkenstein 14
Toronto 14
Phoenix 13
Redmond 12
Abbiategrasso 10
Redwood City 10
Des Moines 8
Moscow 7
Munich 7
Cambridge 5
Bangkok 4
Brasília 4
Brno 4
Clearwater 4
Houston 4
Lima 4
Long Beach 4
Taipei 4
Augsburg 3
Badia Polesine 3
Guangzhou 3
Gunzenhausen 3
Hangzhou 3
Havana 3
Kemerovo 3
Monmouth Junction 3
Stockholm 3
Sydney 3
São Paulo 3
Athens 2
Carbonara al Ticino 2
Central 2
Chisinau 2
Cupertino 2
Delhi 2
Duncan 2
Kampala 2
Kuala Lumpur 2
Lübeck 2
Melbourne 2
Milwaukee 2
Mykolayiv 2
Procida 2
Pulandian 2
St Petersburg 2
Turin 2
Vienna 2
Vittoria 2
Alma 1
Almaty 1
Arvada 1
Auckland 1
Azilda 1
Baltimore 1
Belgrade 1
Bilgi 1
Brescia 1
Brisbane 1
Bristol 1
Caloocan City 1
Central District 1
Chengdu 1
Chennai 1
Chicago 1
Colchester 1
Dongguan 1
Douglas 1
Dundee 1
Durban 1
Englewood 1
Totale 5.898
Salva come PNG Salva come JPEG
Nome #
CAD in TAVI patients: relevance of disease complexity 65
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 65
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 64
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 62
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 62
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 61
2014 ESC/EACTS Guidelines on myocardial revascularization 61
2014 ESC/EACTS Guidelines on myocardial revascularization. 61
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 60
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 60
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 59
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 59
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 58
2014 ESC/EACTS Guidelines on myocardial revascularization 58
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 57
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 57
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 57
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 56
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 56
2018 ESC/EACTS Guidelines on myocardial revascularization 56
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 56
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 55
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 55
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 54
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 54
2018 ESC/EACTS Guidelines on myocardial revascularization. 54
Another reason to endorse and spread guidelines 54
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 54
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 53
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 53
Coronary stents: novel developments 52
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis 52
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 52
Management of ST-elevation myocardial infarction according to European and American guidelines. 51
State of the art: coronary artery stents - past, present and future. 51
2018 ESC/EACTS Guidelines on myocardial revascularization 51
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 51
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 50
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 50
The synergy stent in high-bleeding risk patients: why design matters 49
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 49
Myocardial revascularization appropriateness in Italy: Measuring the unmeasured 48
Are the culprit lesions severely stenotic? 48
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 48
The Valsalva maneuver in the diagnosis of patent foramen ovale. 47
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 47
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 47
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 46
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 46
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 46
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 46
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 46
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 46
Severe aortic stenosis and coronary artery disease. 46
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 46
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 46
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 46
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 45
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 45
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 45
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study 45
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 45
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 45
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators 44
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 43
Higher in-hospital mortality during weekend admission for acute coronary syndrome: a large-scale cross-sectional Italian study 43
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 43
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 43
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 43
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 43
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 43
Drug-Eluting Coronary Artery Stents 42
Role of Niacin in current clinical practice: A systematic review 42
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 42
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials 42
New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry. 42
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents A Patient-Level Pooled Analysis of Randomized Controlled Trials 42
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 42
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 42
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 41
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 41
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 41
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. 40
Quantitative angiographic characterization of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. 40
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 40
Early Doppler-echocardiography evaluation of 597 prosthetic aortic valves. 39
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. 39
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 39
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. 39
Structure and functioning of the Heart Team: primum non nocere 39
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration 39
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 38
Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. 38
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 38
Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat. 38
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 38
Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and 1-year mortality after TAVI: a meta-analysis of adjusted observational results. 38
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 38
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial 37
Three-Year Clinical Follow-Up of the Unrestricted Use of Sirolimus-Eluting Stents as Part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry 37
Totale 4.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.801
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/20211.812 4 12 3 4 13 494 338 135 381 240 2 186
2021/2022902 24 9 16 245 6 2 21 148 73 68 246 44
2022/20232.880 421 110 236 313 315 206 13 213 514 287 192 60
2023/20242.041 210 147 392 116 98 263 143 125 20 49 189 289
2024/2025199 44 32 43 31 49 0 0 0 0 0 0 0
Totale 7.838